HOUSTON, Feb. 20, 2018 -- Amplify Energy Corp. (“Amplify” or the “Company”) (OTCQX:AMPY) announced today that it will report fourth quarter and full year 2017 financial and operating results on March 7, 2018. Following the announcement, management will host a conference call at 10:00 a.m. CT to discuss the Company’s results. Interested parties are invited to participate in the conference call by dialing (833) 883-4379 (Conference ID: 2084357) at least 15 minutes prior to the start of the call or via the internet at www.amplifyenergy.com. A replay of the call will be available on Amplify’s website or by phone at (855) 859-2056 (Conference ID: 2084357) for a fourteen-day period following the call.
About Amplify Energy
Amplify Energy Corp. is an independent oil and natural gas company engaged in the acquisition, development, exploration and production of oil and natural gas properties. The Company’s operations are focused in East Texas / North Louisiana, the Rockies, offshore California and South Texas.
For more information, visit www.amplifyenergy.com.
Contacts
Investors:
Amplify Energy
Bobby Stillwell – Chief Financial Officer
(713) 588-8347
[email protected]
Martyn Willsher – Treasurer
(713) 588-8346
[email protected]


FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility
Anta Sports Expands Global Footprint With Strategic Puma Stake
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade 



